Ventipulmin or Clenbuterol provides bronchodilating properties with minimum effect on the cardiovascular systemAdd this item to your cart:
**Note: This product requires a veterinarian's prescription to purchase.At checkout you will need to provide your
veterinarian's FAX or email address. We will then send him or her a prescription verification that he or she
will need to sign and return before we can ship you this product.
* Only FDA-approved solution to relieve reversible bronchospasm
* Six to eight hour duration of effect
* Treat-to-effect dose schedule
* Colorless, palatable, oral syrup
Dosage & Administration:
Remove safety cap and sea
Replace with enclosed dispensing cap.
Connect syringe without needle to dispensing tip and draw out appropriate volume of VENTIPULMIN Syrup clenbuterol hydrochloride.
Administer to horse orally twice a day b.i.d.. Initial dose is 0.5 mL/100 lbs body weight 0.8 mcg/kgtwice daily.
See package insert for complete dasage schedule. Follow your Veterinarians instructions for dosage and administration.
Recommended duration of treatment at effective dose is 30 days.
At end of 30-day treatment perild, drug should be withdrawn to determine recurrence of signs.
If signs return, repeat 30-day treatment regimen.
Store at controlled room temperature 15-30 degrees C 59-86 degrees F.
The safety cap should be placed on the bottle when not in use.
VENTIPULMIN Syrup should not be used in pregnant mares near term or in horses suspected of having cardiovascular impairment.
This product is not for human use or for use in animals intended for food.
Federal U.S.AA. law restricts this drug to use by or on the order of a licensed veterinarian.
The reproduction effect in breeding stallions and brood mares has not been determined.
Treatment starting with dosages higher than initial dose is not recommended.
Keep out of reach of children. In case of accidental ingestion, contact a physician immediately.
Clenbuterol, like other beta adrenergic agonists, can produce significant cardiovascular effects in some people as evidenced by elevated pulse rate, blood pressure changes and/or ECG changes.